HTA pilot projects and RWE’s usefulness in reassessments of effectiveness and value: an interview with Ashley Jaksa

9 Jun 2022

Written by ASHLEY JAKSA (AETION)

Health economics Health technology assessment Interviews ISPOR Market access Real-world evidence

In this interview with Ashley Jaksa, Market Access Scientific Strategy Lead at Aetion (NY, US), we discuss the topic of Ashley’s recent panel at ISPOR 2022 (DC, US, 15–18 May 2022). We delve into what we can learn from health technology assessment (HTA) pilot projects regarding the usefulness of real-world evidence (RWE) in the reassessment of effectiveness and value, the limitations of this and much more. Biography: Ashley Jaksa is the Market Access Scientific Strategy Lead at Aetion. Her role focuses on forming partnerships with regulatory and HTA agencies to enhance their utilization of RWE, utilize RWE to support their decision-making...